Prenatal diagnosis of 13 thalassaemia can at present be accomplished in the great majority of cases by amniocyte or trophoblast DNA analysis. 1-3 Two different procedures are used: (1) the direct identification of the mutation by oligonucleotide hybridisation or restriction endonuclease analysis, and (2) linkage analysis with polymorphic restriction enzyme sites in the 13 globin gene cluster. A critical prerequisite for linkage analysis is the knowledge of linkage phase, which allows distinction of the normal from the 13 16 Oligonucleotide and restriction endonuclease analysis was performed using previously described methods. '7 18 DNA from prospective parents was screened with four oligonucleotide probes complementary to the most frequent mutations in Italians, namely the G-A substitution at and subject homozygous for P39 mutation (bottom). 
